4//SEC Filing
TURKEL CATHERINE C. 4
Accession 0001562180-19-003055
CIK 0001404281other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 4:12 PM ET
Size
7.3 KB
Accession
0001562180-19-003055
Insider Transaction Report
Form 4
TURKEL CATHERINE C.
Chief Development Officer
Transactions
- Sale
Common Stock
2019-05-20$1.96/sh−7,623$14,953→ 90,576 total - Sale
Common Stock
2019-05-21$1.91/sh−1,914$3,658→ 88,662 total
Footnotes (3)
- [F1]Shares were sold to cover the reporting person's taxes due on the vesting of restricted stock units.
- [F2]This transaction was executed in multiple trades at prices ranging from $1.90 to $2.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $1.90 to $1.945. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Novus Therapeutics, Inc.
CIK 0001404281
Entity typeother
Related Parties
1- filerCIK 0001705278
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 4:12 PM ET
- Size
- 7.3 KB